| 1. |
- Lopez-Garcia, SC, et al.
(författare)
-
Treatment and long-term outcome in primary distal renal tubular acidosis
- 2019
-
Ingår i: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. - : Oxford University Press (OUP). - 1460-2385. ; 34:6, s. 981-991
-
Tidskriftsartikel (refereegranskat)
|
|
| 2. |
- Maffi, P., et al.
(författare)
-
Targeting CXCR1/2 Does Not Improve Insulin Secretion After Pancreatic Islet Transplantation: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in Type 1 Diabetes
- 2020
-
Ingår i: Diabetes Care. - : American Diabetes Association. - 0149-5992 .- 1935-5548. ; 43:4, s. 710-718
-
Tidskriftsartikel (refereegranskat)abstract
- OBJECTIVE Reparixin is an inhibitor of CXCR1/2 chemokine receptor shown to be an effective anti-inflammatory adjuvant in a pilot clinical trial in allotransplant recipients. RESEARCH DESIGN AND METHODS A phase 3, multicenter, randomized, double-blind, parallel-assignment study () was conducted in recipients of islet allotransplants randomized (2:1) to reparixin or placebo in addition to immunosuppression. Primary outcome was the area under the curve (AUC) for C-peptide during the mixed-meal tolerance test at day 75 +/- 5 after the first and day 365 +/- 14 after the last transplant. Secondary end points included insulin independence and standard measures of glycemic control. RESULTS The intention-to-treat analysis did not show a significant difference in C-peptide AUC at both day 75 (27 on reparixin vs. 18 on placebo, P = 0.99) and day 365 (24 on reparixin vs. 15 on placebo, P = 0.71). There was no statistically significant difference between treatment groups at any time point for any secondary variable. Analysis of patient subsets showed a trend for a higher percentage of subjects retaining insulin independence for 1 year after a single islet infusion in patients receiving reparixin as compared with patients receiving placebo (26.7% vs. 0%, P = 0.09) when antithymocyte globulin was used as induction immunosuppression. CONCLUSIONS In this first double-blind randomized trial, islet transplantation data obtained with reparixin do not support a role of CXCR1/2 inhibition in preventing islet inflammation-mediated damage.
|
|
| 3. |
- Persson, Katarina, et al.
(författare)
-
Catalytic combustion of methane over bimetallic Pd-Pt catalysts: The influence of support materials
- 2006
-
Ingår i: Applied Catalysis B: Environmental. - : Elsevier BV. - 0926-3373. ; 66, s. 175-185
-
Tidskriftsartikel (refereegranskat)abstract
- The effect of support material on the catalytic performance for methane combustion has been studied for bimetallic palladium-platinum catalysts and compared with a monometallic palladium catalyst on alumina. The catalytic activities of the various catalysts were measured in a tubular reactor, in which both the activity and stability of methane conversion were monitored. In addition, all catalysts were analysed by temperature-programmed oxidation and in situ XRD operating at high temperatures in order to study the oxidation/reduction properties.The activity of the monometallic palladium catalyst decreases under steady-state conditions, even at a temperature as low as 470 degrees C. In situ XRD results showed that no decomposition of bulk PdO into metallic palladium occurred at temperatures below 800 degrees C. Hence, the reason for the drop in activity is probably not connected to the bulk PdO decomposition.All Pd-Pt catalysts, independently of the support, have considerably more stable methane conversion than the monometallic palladium catalyst. However. dissimilanties in activity and ability to reoxidise PdO were observed for the various support materials. Pd-Pt supported on Al2O3 was the most active catalyst in the low-temperature region, Pd-Pt supported on ceria-stabilised ZrO2 was the most active between 620 and 800 degrees C, whereas Pd-Pt supported on LaMnAl11O19 was superior for temperatures above 800 degrees C. The ability to reoxidise metallic Pd into PdO was observed to vary between the supports. The alumina sample showed a very slow reoxidation, whereas ceria-stabilised ZrO2 was clearly faster
|
|
